As of December 2024, NovaBay Pharmaceuticals has a market cap of $3.46M. This makes NovaBay Pharmaceuticals the world's 33157th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $991.80K | -24.05% |
2023 | $1.31M | -89.74% |
2022 | $12.73M | -85.21% |
2021 | $86.06M | -45.97% |
2020 | $159.28M | 8.91% |
2019 | $146.26M | -17.17% |
2018 | $176.58M | -79.93% |
2017 | $879.82M | 16.67% |
2016 | $754.13M | 63.37% |
2015 | $461.62M | -87.17% |
2014 | $3.60B | -48.78% |
2013 | $7.03B | 8.85% |
2012 | $6.46B | -15.67% |
2011 | $7.66B | -19.28% |
2010 | $9.48B | -19.42% |
2009 | $11.77B | 101.96% |
2008 | $5.83B | -72.87% |
2007 | $21.48B | - |